|
TTC7B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.338100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.936600E-03 |
| Normal-vs-Stage2 |
9.366200E-01 |
| Normal-vs-Stage3 |
5.131800E-01 |
| Normal-vs-Stage4 |
1.411500E-02 |
| Stage1-vs-Stage2 |
2.348200E-01 |
| Stage1-vs-Stage3 |
6.006400E-02 |
| Stage1-vs-Stage4 |
5.365200E-01 |
| Stage2-vs-Stage3 |
6.879800E-01 |
| Stage2-vs-Stage4 |
1.306990E-01 |
| Stage3-vs-Stage4 |
3.460200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.506300E-02 |
| Normal-vs-AfricanAmerican |
8.898400E-02 |
| Normal-vs-Asian |
1.460610E-01 |
| Caucasian-vs-AfricanAmerican |
9.975000E-01 |
| Caucasian-vs-Asian |
7.771000E-01 |
| AfricanAmerican-vs-Asian |
7.337400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.386400E-02 |
| Normal-vs-Female |
5.900600E-01 |
| Male-vs-Female |
1.408020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.282150E-01 |
| Normal-vs-Extreme_Weight |
1.984130E-02 |
| Normal-vs-Obese |
8.049400E-01 |
| Normal-vs-Extreme_Obese |
9.515600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.293400E-01 |
| Normal_Weight-vs-Obese |
3.589400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.764000E-01 |
| Extreme_Weight-vs-Obese |
1.693220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.545800E-01 |
| Obese-vs-Extreme_Obese |
9.542200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.123200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.883450E-01 |
| Normal-vs-Age(61-80Yrs) |
4.615300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.853600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.034600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.558360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.031000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.053370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.007800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.197200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.264200E-03 |
| Normal-VS-Type2 PRCC |
4.827000E-01 |
| Normal-VS-KIRP CIMP |
3.072600E-01 |
| Normal-VS-Unclassified PRCC |
7.364600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.578590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.056300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.576000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.949400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.182800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.742600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.231400E-01 |
| Normal-vs-N1 |
6.334600E-01 |
| Normal-vs-N2 |
1.066620E-01 |
| N0-vs-N1 |
9.526400E-01 |
| N0-vs-N2 |
5.827200E-01 |
| N1-vs-N2 |
3.911000E-01 |
|
|
